Ken Griffin’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$64.7M Buy
+103,659
New +$60.7M 0.01% 1317
2026
Q2
– Sell
-808
Closed -$373K – 14406
2026
Q1
$388K Sell
808
-58,932
-99% -$30.2M ﹤0.01% 9877
2025
Q4
$33.6M Buy
59,740
+36,827
+161% +$20.9M 0.01% 1797
2025
Q3
$11.8M Sell
22,913
-46,089
-67% -$20.1M ﹤0.01% 3019
2025
Q2
$21.7M Buy
+69,002
New +$20.7M ﹤0.01% 2042
2025
Q1
– Sell
-8,107
Closed -$2.73M – 15149
2024
Q4
$2.69M Sell
8,107
-8,145
-50% -$2.76M ﹤0.01% 5025
2024
Q3
$5.42M Buy
16,252
+6,597
+68% +$2.51M ﹤0.01% 3805
2024
Q2
$3.98M Sell
9,655
-83,736
-90% -$33.2M ﹤0.01% 4111
2024
Q1
$37.7M Buy
93,391
+87,313
+1,437% +$30.7M 0.01% 1443
2023
Q4
$1.86M Sell
6,078
-31,178
-84% -$8.42M ﹤0.01% 5486
2023
Q3
$9.02M Sell
37,256
-35,159
-49% -$8.99M ﹤0.01% 2818
2023
Q2
$17.4M Buy
72,415
+70,271
+3,278% +$14.6M ﹤0.01% 2031
2023
Q1
$403K Sell
2,144
-41,965
-95% -$8.68M ﹤0.01% 8755
2022
Q4
$9.37M Buy
44,109
+41,354
+1,501% +$8.26M ﹤0.01% 2926
2022
Q3
$433K Sell
2,755
-10,219
-79% -$1.63M ﹤0.01% 8783
2022
Q2
$1.94M Buy
12,974
+4,911
+61% +$711K ﹤0.01% 5607
2022
Q1
$1.32M Sell
8,063
-21,917
-73% -$3.61M ﹤0.01% 7059
2021
Q4
$6.52M Buy
29,980
+27,437
+1,079% +$5.75M ﹤0.01% 3836
2021
Q3
$481K Buy
+2,543
New +$464K ﹤0.01% 9969
2021
Q2
– Sell
-22,230
Closed -$3.84M – 14094
2021
Q1
$3.65M Sell
22,230
-19,356
-47% -$2.96M ﹤0.01% 4991
2020
Q4
$5.79M Buy
41,586
+12,763
+44% +$1.61M ﹤0.01% 3433
2020
Q3
$3.22M Buy
28,823
+22,629
+365% +$2.62M ﹤0.01% 3865
2020
Q2
$576K Sell
6,194
-5,538
-47% -$471K ﹤0.01% 6817
2020
Q1
$861K Buy
+11,732
New +$1.02M ﹤0.01% 5598
2019
Q3
– Sell
-7,101
Closed -$537K – 9534
2019
Q2
$464K Sell
7,101
-13,511
-66% -$779K ﹤0.01% 6940
2019
Q1
$1.22M Buy
20,612
+1,987
+11% +$119K ﹤0.01% 5238
2018
Q4
$986K Sell
18,625
-307,083
-94% -$16.9M ﹤0.01% 5330
2018
Q3
$19.5M Buy
325,708
+158,502
+95% +$8.67M 0.01% 1412
2018
Q2
$7.19M Buy
167,206
+161,099
+2,638% +$6.51M ﹤0.01% 2299
2018
Q1
$213K Sell
6,107
-2,511
-29% -$91.7K ﹤0.01% 7263
2017
Q4
$312K Sell
8,618
-13,515
-61% -$474K ﹤0.01% 6398
2017
Q3
$706K Buy
22,133
+15,213
+220% +$465K ﹤0.01% 4828
2017
Q2
$201K Sell
6,920
-24,276
-78% -$681K ﹤0.01% 6562
2017
Q1
$931K Buy
+31,196
New +$1.01M ﹤0.01% 4113
2016
Q4
– Sell
-52,162
Closed -$1.56M – 7610
2016
Q3
$1.56M Buy
+52,162
New +$1.52M ﹤0.01% 3257

Other funds holding MEDP

Ken Griffin's MEDP Position: Q3 2026 in Review

Ken Griffin opened a new position in Medpace (MEDP) in Q3 2026: 103,659 shares worth $64.7M. The stake represents 0.01% of the portfolio and ranks #1317 among its holdings. This is a return to the name: Ken Griffin previously reported a position in MEDP as recently as Q1 2026.

Ken Griffin first reported a position in MEDP in Q3 2016 and has held it in 35 quarters since. 762 funds tracked by Wall St. Rank hold MEDP as of Q3 2026.

  • Ken Griffin held 103,659 shares of Medpace worth $64.7M as of Q3 2026.
  • Medpace was a new Ken Griffin position in Q3 2026.
  • Medpace made up 0.01% of Ken Griffin's portfolio in Q3 2026, its #1317 holding.
  • Ken Griffin first reported a position in Medpace in Q3 2016 and has held it in 35 quarters since.
  • 762 funds tracked by Wall St. Rank held Medpace as of Q3 2026.

Based on Citadel Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.